Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab.
Tachinami H, Tomihara K, Yamada SI, Ikeda A, Imaue S, Hirai H, Nakai H, Sonoda T, Kurohara K, Yoshioka Y, Hasegawa T, Naruse T, Niiyama T, Shimane T, Ueda M, Yanamoto S, Akashi M, Umeda M, Kurita H, Miyazaki A, Arai N, Hayashi R, Noguchi M.
Tachinami H, et al. Among authors: arai n.
Br J Oral Maxillofac Surg. 2023 May;61(4):320-326. doi: 10.1016/j.bjoms.2023.03.012. Epub 2023 Mar 31.
Br J Oral Maxillofac Surg. 2023.
PMID: 37061418